Health experts call on government to increase transparency around drug research
Researchers say not having open access to studies that were done to allow the drugs to be sold in Canada means physicians don’t have all the information they need to have faith in a drug when prescribing it to their patients.
Health Minister Jane Philpott is facing calls to increase transparency around the research that goes into drugs approved for sale in Canada. The Hill Times photograph by Jake Wright
More Stories In This Section
Shared Services likely to become ‘money pit,’ says Canada’s former chief statistician who quit two weeks ago